APA

Coussy F., Lallemand F., Vacher S., Schnitzler A., Chemlali W., Caly M., Nicolas A., Richon S., Meseure D., El Botty R., De-Plater L., Fuhrmann L., Dubois T., Roman-Roman S., Dangles-Marie V., Marangoni E. & Bièche I. (20170822). Clinical value of R-spondins in triple-negative and metaplastic breast cancers. : British journal of cancer.

Chicago

Coussy F, Lallemand F, Vacher S, Schnitzler A, Chemlali W, Caly M, Nicolas A, Richon S, Meseure D, El Botty R, De-Plater L, Fuhrmann L, Dubois T, Roman-Roman S, Dangles-Marie V, Marangoni E and Bièche I. 20170822. Clinical value of R-spondins in triple-negative and metaplastic breast cancers. : British journal of cancer.

Harvard

Coussy F., Lallemand F., Vacher S., Schnitzler A., Chemlali W., Caly M., Nicolas A., Richon S., Meseure D., El Botty R., De-Plater L., Fuhrmann L., Dubois T., Roman-Roman S., Dangles-Marie V., Marangoni E. and Bièche I. (20170822). Clinical value of R-spondins in triple-negative and metaplastic breast cancers. : British journal of cancer.

MLA

Coussy F, Lallemand F, Vacher S, Schnitzler A, Chemlali W, Caly M, Nicolas A, Richon S, Meseure D, El Botty R, De-Plater L, Fuhrmann L, Dubois T, Roman-Roman S, Dangles-Marie V, Marangoni E and Bièche I. Clinical value of R-spondins in triple-negative and metaplastic breast cancers. : British journal of cancer. 20170822.